Ionic Liquid Biocatalyst Solvent for Enzyme Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional biocatalyst solvents fail to dissolve enzymes at high concentrations and retain their activity over a wide temperature range, leading to conformational destruction and activity deterioration during storage and use.

Innovation Solution

A biocatalyst solvent comprising an anhydrous or hydrous ionic liquid with a quaternary ammonium cation and a hydrogen-bondable anion, such as sulfate or phosphate, which forms hydrogen bonds with enzyme residues, enhancing solubility and stability at high concentrations and varying temperatures.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If conventional solvents are used for biocatalyst storage, then the biocatalyst can be stored in solution form, but the biocatalyst undergoes conformational destruction and activity deterioration

Engineering Contradiction:
Improvestorage convenienceVSAvoidbiocatalyst activity retention
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent changes the chemical parameters of the storage medium by using ionic liquids with specific cation-anion combinations (e.g., choline chloride with organic acid anions) instead of conventional aqueous buffers. This parameter change enables the solvent to form protective interactions with the biocatalyst, preventing conformational destruction while maintaining solution-state storage convenience.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs composite ionic liquid systems combining specific cations (e.g., choline, amino acid-derived cations) with specific anions (e.g., acetate, propionate, butyrate) to create a synergistic storage medium. This composite approach allows the solvent to simultaneously provide structural stability, prevent aggregation, and maintain biocatalyst activity over extended periods.

Inventive Principle:
Principle #40Composite materials

2Quantity of substance

If the biocatalyst storage concentration is increased to improve efficiency, then more biocatalyst can be stored in the same volume, but the biocatalyst molecules aggregate and lose activity

Engineering Contradiction:
Improvestorage concentrationVSAvoidbiocatalyst activity
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The ionic liquid acts as an intermediary between biocatalyst molecules at high concentrations. The cation-anion pairs in the ionic liquid insert themselves between biocatalyst molecules, preventing direct aggregation while maintaining high storage concentration. This intermediary effect allows dense packing without loss of individual biocatalyst molecule activity.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the electrostatic and hydrophobic parameters of the storage medium by selecting ionic liquids with appropriate cation-anion combinations. These parameter changes create repulsive or steric barriers between biocatalyst molecules even at high concentrations, preventing aggregation while maximizing storage density.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If freeze preservation is used to maintain biocatalyst conformation, then the biocatalyst structure is preserved, but ice formation destroys the conformation and requires special apparatus

Engineering Contradiction:
Improveconformation preservationVSAvoidspecial apparatus requirement
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent exploits the phase transition properties of ionic liquids, which remain liquid at low temperatures down to their eutopic points (some below -50°C). This allows the biocatalyst to be stored in liquid form at refrigeration temperatures without freezing, eliminating ice formation damage and the need for cryogenic apparatus while maintaining conformational stability.

Inventive Principle:
Principle #36Phase transitions

Solution Approach 2:

The patent changes the thermal parameters of the storage system by using ionic liquids with depressed freezing points. This parameter change allows storage at conventional refrigeration temperatures (4°C) or even lower without phase change to ice, eliminating the need for complex freeze-preservation infrastructure while maintaining structural integrity.

Inventive Principle:
Principle #35Parameter changes

4Reliability

If polyhydric alcohols or proteins are added as stabilizers to prevent deactivation, then some activity is retained, but enzyme activity deteriorates with respect to storage concentration, temperature, or period

Engineering Contradiction:
Improveenzyme activity retentionVSAvoidstorage period stability
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The ionic liquid components (cation and anion) act as dual intermediaries that simultaneously stabilize the biocatalyst structure and prevent destabilizing interactions. The cation interacts with negatively charged regions while the anion interacts with positively charged regions, providing comprehensive protective coverage that maintains activity stability over extended storage periods regardless of concentration or temperature variations.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent uses composite ionic liquid systems where specific cation-anion pairs work synergistically to provide multi-faceted protection. This composite stabilizing system addresses multiple degradation pathways simultaneously (conformational change, aggregation, oxidation) providing superior long-term stability compared to single-component stabilizers.

Inventive Principle:
Principle #40Composite materials

Data Source

PatentEP3766969B1Biocatalyst solvent using ionic liquid, and biocatalyst solution containing biocatalyst and said solvent
Publication Date: 2023.10.04 MIYOSHI OIL & FAT
  • EP3766969B1 patent drawing
  • EP3766969B1 patent drawing
  • EP3766969B1 patent drawing

AI summary

There is provided a biocatalyst solvent which is capable of dissolving a biocatalyst in a liquid state while maintaining the activity of the biocatalyst at a high concentration from a low temperature to a high temperature, and is capable of storing the biocatalyst for a long time period; and a biocatalyst solution using the biocatalyst solvent. Disclosed is a biocatalyst solvent which consists of an ionic liquid including a quaternary ammonium cation represented by the following Formula (I) and an anion: [Chemical Formula 1]         N+[Ra]n[Rb]4-n     (I) wherein Ra's each independently represent a hydroxyalkyl group having one or more hydroxyl groups and an a linear or branched alkyl moiety having 1 to 10 carbon atoms, in which the alkyl moiety may contain an oxygen atom; a carboxyalkyl group having one or more carboxyl groups and a linear or branched alkyl moiety having 1 to 10 carbon atoms, in which the alkyl moiety may contain an oxygen atom; or a hydroxycarboxyalkyl group having one or more hydroxyl groups, one or more carboxyl groups and a linear or branched alkyl moiety having 1 to 10 carbon atoms, in which the alkyl moiety may contain an oxygen atom; Rb's each independently represent a hydrogen atom, or a linear or branched alkyl group having 1 to 5 carbon atoms; and n represents an integer from 1 to 4.